Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,61 USD | -2,17% | -1,37% | -58,93% |
Vakgebied
Aantal werknemers: 597
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Product
94,8
%
| 126 | 94,7 % | 222 | 94,8 % | +76,62% |
Service
5,2
%
| 7 | 5,3 % | 12 | 5,2 % | +75,24% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 133 | 100,0 % | 234 | 100,0 % | +76,55% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Foley
CEO | Chief Executive Officer | 58 | 05-09-17 |
Tobin Schilke
DFI | Director of Finance/CFO | 49 | 05-11-18 |
Azita Nejad
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-14 |
Conor Gallagher
CTO | Chief Tech/Sci/R&D Officer | - | 09-05-18 |
David Hollander
CTO | Chief Tech/Sci/R&D Officer | 50 | 17-10-22 |
Jessica Serra
IRC | Investor Relations Contact | - | - |
Erica Jordan
PRN | Corporate Officer/Principal | - | - |
Dwight Moxie
LAW | General Counsel | 48 | 01-02-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Angus Russell
CHM | Chairman | 68 | 01-03-11 |
Mark Foley
CEO | Chief Executive Officer | 58 | 05-09-17 |
Jill Beraud
BRD | Director/Board Member | 63 | 04-06-19 |
Julian Gangolli
BRD | Director/Board Member | 66 | 01-07-16 |
Carey Kolaja
BRD | Director/Board Member | 51 | 01-03-21 |
Olivia Ware
BRD | Director/Board Member | 67 | 06-03-21 |
Vladimir Coric
BRD | Director/Board Member | 53 | 01-03-23 |
Christian Nolet
BRD | Director/Board Member | 67 | 16-07-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 104 215 614 | 95 385 648 ( 91,53 %) | 0 | 91,53 % |
Bedrijfsgegevens
Revance Therapeutics, Inc.
1222 Demonbreun Street Suite 2000
37203, Nashville
+615 724 7755
http://www.revance.comSector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-58,93% | 385 mln. | |
-3,94% | 87,17 mld. | |
+2,76% | 40,1 mld. | |
-16,98% | 31,38 mld. | |
+57,86% | 25,12 mld. | |
-16,24% | 15,59 mld. | |
-9,12% | 12 mld. | |
-42,56% | 11,8 mld. | |
-17,10% | 11,8 mld. | |
+6,89% | 8,81 mld. |
- Beurs
- Aandelen
- Koers RVNC
- Onderneming Revance Therapeutics, Inc.